REGENERCELL
Live / Allowed — First extension granted (statement of use) (as of 23 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 09 Aug 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98691907
- Mark type
- Word mark
- Filed
- 09 Aug 2024
- Published for opposition
- 31 Dec 2024
- Attorney of record
- JAMES COLE
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for use in soft tissue reconstruction, namely, biologic collagen matrix derived from bovine dermis
Owner
- AVITA Medical Americas, LLC, Valencia, CA, US
- AVITA Medical Americas, LLC, Valencia, CA, US
Board proceedings on this mark
- Opposition No. 91299983 — Regeneron Pharmaceuticals, Inc. v. AVITA Medical Americas, LLC, filed 27 Jun 2025 (Terminated)
- Extension of Time to Oppose No. 98691907 — Regeneron Pharmaceuticals, Inc. v. AVITA Medical Americas, LLC, filed 29 Jan 2025 (Terminated)
Prosecution history
- 24 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Mar 2026 — SOU EXTENSION 1 GRANTED
- 23 Mar 2026 — SOU EXTENSION 1 FILED
- 23 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 23 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Aug 2025 — TTAB RELEASE CASE TO TRADEMARKS
- 15 Aug 2025 — OPPOSITION TERMINATED NO. 999999
- 15 Aug 2025 — OPPOSITION DISMISSED NO. 999999
- 29 Jun 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 27 Jun 2025 — OPPOSITION INSTITUTED NO. 999999
- 29 Jan 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 31 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2024 — PUBLISHED FOR OPPOSITION
- 25 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER